Eflucimibe [CAS 202340-45-2]

Eflucimibe (F 12511) is a new acyl-coenzyme A cholesterol O-acyltransferase (ACAT) inhibitor. Eflucimibe can be used in the research of atherosclerosis[1].

[202340-45-2]

C29H43NO2S

469.72

CC(C(C)=C(C(C)=C1)O)=C1NC([C@H](C2=CC=CC=C2)SCCCCCCCCCCCC)=O

Acyltransferase

98.6

DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

-20°C, 3 years; 4°C, 2 years (Powder)

Room Temperature